S&P 500
733.58
-1.45%
DOW
516.62
-0.09%
NASDAQ
713.65
-3.29%
Russell
295.32
-0.96%
VIX
28.00
+8.28%
FTSE
45.57
-0.26%
Nikkei
92.75
-4.35%
BTC
62,401.01
-3.14%
ETH
1,662.44
-4.07%
Gold
377.32
-1.89%
Oil
111.26
-1.27%
Silver
55.73
-5.40%
S&P 500
733.58
-1.45%
DOW
516.62
-0.09%
NASDAQ
713.65
-3.29%
Russell
295.32
-0.96%
VIX
28.00
+8.28%
FTSE
45.57
-0.26%
Nikkei
92.75
-4.35%
BTC
62,401.01
-3.14%
ETH
1,662.44
-4.07%
Gold
377.32
-1.89%
Oil
111.26
-1.27%
Silver
55.73
-5.40%
Stock
Ti
News
Markets
Stocks
Screener
Calendar
Watchlist
Loading...
Home
/
Stocks
/
RIGL
/
News
RIGL
NASDAQ · Biotechnology
Rigel Pharmaceuticals Inc
Small-Cap Stocks
Biotech Stocks
Healthcare Stocks
$35.73
+2.82 (+8.57%)
☆ Watch
As of Jun 22, 10:02 PM ET ·
Overview
Earnings
Forecast
Financials
News
Peers
RIGL News
1 articles
Pfizer Shares Edge Up as Rigel Completes Veppanu Licensing Deal
Pfizer shares edged up after Rigel completed a Veppanu licensing deal with Arvinas, providing a $35 million payment to Pfizer.
Earnings
Jun 16
↑